Authors


Michael Devlin, MD

Latest:

Treatment for Eating Disorders and the Path to Wellness

Podcast: Experts summarize effective treatment options for patients with eating disorders and discuss common features, medical components of anorexia and bulimia, behavioral features, and psychological symptoms.


Michael E. Henry, MD

Latest:

In Defense of ECT

Research data shows that ECT is often more effective than alternative treatments, and safe too.


Michael E. Thase, MD

Latest:

Rejecting the Accusation of a Violated STAR*D Protocol

The original STAR*D authors refute claims of a violated protocol.


Michael Farrell, FRCP FRCPsych

Latest:

Illicit Drug Dependence Across the Globe: Results From the Global Burden of Disease 2010 Study

How prevalent is dependence on amphetamines, cocaine, opioids, and other illicit drugs across the world? What is the associated disease burden? Insights here.


Michael Flaum, MD

Latest:

A Crisis in the Public Service Psychiatric Workforce

Here's what's known about the growing shortage of psychiatrists -- why it's happening-- and possible solutions.


Michael Garrett, MD

Latest:

Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia

Our study suggests that most delusional patients, even those with high positive symptom scores, may have at least 1 RFD that precedes a clinical intervention specifically directed toward encouraging doubt. These preexisting “islands of doubt” may offer a useful foothold to begin the CBT process.


Michael H. Levinson, MD

Latest:

Psychiatry’s Underground Economy

It seems to this psychiatrist that a significant cohort of his colleagues conduct their practices in what might best be described as an “underground economy”: a system of services and charges disconnected from the conventional constructs by which these activities are presumably measured.


Michael Hann, MD, MBA, MS

Latest:

A First-Episode Psychosis Treatment Program: “The Disease Doesn’t Define Me”

The Psychiatric Transition Program at the Naval Medical Center in San Diego is a specialized first-episode psychosis program that provides coordinated specialty care to active-duty service members with serious mental illness.


Michael Hoefer, MD

Latest:

Addiction Psychiatry: Clinical Insights

This brief communication highlights clinically applicable information and take-home points presented at the American Academy of Addiction Psychiatry Annual Meeting.


Michael I. Casher, MD

Latest:

Confounding Factors in Treatment-Resistant Depression (Part 2): Comorbidities and Treatment Resistance

The role of subtyping and bipolarity in TRD was discussed in Part 1 of this 2-part article. Here we review a number of the most common confounding factors of TRD but limit our scope to comorbidities that can be directly addressed and treated by psychiatrists.


Michael J. Detke, MD, PhD

Latest:

Parenteral Antidepressants: Is America Ready?

In spite of the enormous success of antidepressants, there are surprisingly few that are available in other than oral form. There is now substantial evidence that intravenous administration is well tolerated and may accelerate onset of therapeutic effect. With the possibility of transdermal delivery3/4a noninvasive and painless route of administration requiring no technical support3/4parenteral antidepressants may become more acceptable in this country and warrant further clinical investigation.


Michael J. Labellarte, MD

Latest:

Assessing Risk of QTC Prolongation

Monitoring patients for possible QTC prolongation with psychotropic use can be difficult--even more so in children or adolescents. What screening and treatment techniques should be used for maximum therapeutic benefit with minimum cardiac risk?


Michael J. Manos, PhD

Latest:

Optimizing ADHD Treatment

Weight-based dosing strategies have been used in psychostimulant studies for ADHD in children between the ages of 6 and 12 years. The efficacy of weight-based psychostimulant doses changes throughout early childhood and into adolescence in ways that are not in keeping with weight-based dosing practices. Future treatment and research must explore new possibilities in order to afford patients the most benefit for the least amount of effective drug intervention.


Michael J. Ostacher, MD, MPH

Latest:

Pathology and Management of Treatment Resistance in Bipolar Disorder

The problem of treatment resistance in bipolar disorder begins with its definition. Characterizing the phases of bipolar disorder as manic, mixed, hypomanic, or depressed does not do justice to the reality for many persons with this disorder.


Michael J. Owen, PhD, FRCPsych

Latest:

Intellectual Disability and Psychiatric Comorbidity: Challenges and Clinical Issues

Intellectual disability affects an individual’s functioning in everyday life. The risk for a psychiatric disorder is greater in persons with ID than in those with intelligence in the normal range. Here: the latest information on ID.


Michael J. Owens, PhD

Latest:

Stress Neurobiology and Corticotropin-Releasing Factor

Stress Neurobiology and Corticotropin-Releasing Factor


Michael J. Peterson, MD, PhD

Latest:

Bioethical Challenges for Psychiatrists: Determination of Decisional Capacity

The authors parse myths and facts about decisional capacity, with the goal of preserving patients' dignity and autonomy and helping you mediate conflicts, meet bioethical challenges, and provide compassionate resolutions.


Michael J. Ruckenstein, MD, MSc

Latest:

The Dizzy Patient: How You Can Help

Painstaking elucidation of a patient's symptoms is the key component of the diagnostic workup for dizziness and vertigo. A rational, straightforward, and cost-effective approach that uses minimal, selective diagnostic testing can get to the root of an individual's specific problem.


Michael Jonathan Grinfeld

Latest:

The Outlook for Mental Health Services: A Perfect Storm on Our Hands

Funding for mental health services has never achieved top legislative priority, and reforms requiring parity succeeded only after years of hard-fought battles.


Michael lenn Yee, MD

Latest:

Ms. L, Delirious Mania

To this day, I fiercely debate whether I would want to remember such an experience if it had happened to me. How tortured would I feel?


Michael Linden, MD

Latest:

Why Do Psychiatrists Select or Switch an Antipsychotic?

The increase in diagnostic and therapeutic options has made the selection of the best medical strategy more complex. Physicians are often forced to work and make decisions under time pressure, which complicates matters.


Michael Logan, MD

Latest:

Psychiatric Consultant's Role Continues to Grow at Life Insurance Company

I find expertise is best defined by the attending psychiatrist. I usually ask them whose opinion they respect in the community, whether that person is acceptable to them to do the evaluation and if their conclusions about disability would be acceptable. If the attendings have no one in mind, I have developed a network of excellent forensic psychiatrists around the country from which I can draw. In this case, I make a suggestion, and ask the attending if the particular provider is acceptable.


Michael Miller, MD

Latest:

Q&A: Addiction Medicine

In this podcast, Dr Michael Miller, Director of the American Board of Addiction Medicine, discusses addiction medicine, including the new ASAM, patient placement criteria, and DSM-5 changes.


Michael Miovic, MD

Latest:

An Army of Children

I am a civilian psychiatrist who recently finished 20 months of work as a contractor for the US Army. Going into the job, I expected the degree of combat-related stress I saw in our troops. I was not prepared, however, for the scope of the impact our 2 long wars have had on military children.


Michael P. Bogenschutz, MD

Latest:

5 Classic Hallucinogens Studied in the Treatment of Addictions

This slideshow provides information about the compounds, clinically relevant attributes, approximate dose, and data under study.


Michael Potegal, PhD

Latest:

Helping Children Hospitalized for Rages

Rages are part of a syndrome of severe mood dysregulation, which is defined by markedly increased and frequent reactivity to negative emotional stimuli.


Michael Poyurovsky, MD

Latest:

Exploring OCD Subtypes and Treatment Resistance

Obsessive-compulsive disorder (OCD) is a heterogeneous disorder with a variety of phenotypic expressions. Delineation of clinically distinct subtypes of the disorder may be valuable in predicting treatment response and resistance.


Michael R. Irwin, MD

Latest:

Behavioral Comorbidities in Rheumatoid Arthritis

While tremendous therapeutic advancements have been made, patients with rheumatoid arthritis (RA) have a myriad of comorbidities, including fatigue, depression, and sleep disturbances. Data on the comorbidity of psychiatric disorders with arthritis are also striking: according to the NIMH Catchment Area program, the lifetime prevalence of psychiatric disorders among patients with RA is 63%.


Michael S. Jellinek, MD

Latest:

Black Boxes, Xboxes, and Other Current Concerns

The articles in this Special Report, although far from comprehensive, address an intriguing sample of the many key topics in child and adolescent psychiatry today.


Michael Sperber, MD

Latest:

10 Hallmarks of a Great Psychiatrist

A great psychiatrist knows the disease, the person with the disease, and the way the two interact. Here are tips from a clinician who has devoted his career to treating psychiatric disorders.

© 2024 MJH Life Sciences

All rights reserved.